MALDI-TOF Mass Spectrometry-Based Optochin Susceptibility Testing for Differentiation of <i>Streptococcus pneumoniae</i> from other <i>Streptococcus mitis</i> Group Streptococci

Discrimination of <i>Streptococcus pneumoniae</i> from other <i>Streptococcus mitis</i> group (SMG) species is still challenging but very important due to their different pathogenic potential. In this study, we aimed to develop a matrix-assisted laser desorption/ionization ti...

Full description

Bibliographic Details
Main Authors: Ilka D. Nix, Evgeny A. Idelevich, Andreas Schlattmann, Katrin Sparbier, Markus Kostrzewa, Karsten Becker
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/9/10/2010
_version_ 1797513799787347968
author Ilka D. Nix
Evgeny A. Idelevich
Andreas Schlattmann
Katrin Sparbier
Markus Kostrzewa
Karsten Becker
author_facet Ilka D. Nix
Evgeny A. Idelevich
Andreas Schlattmann
Katrin Sparbier
Markus Kostrzewa
Karsten Becker
author_sort Ilka D. Nix
collection DOAJ
description Discrimination of <i>Streptococcus pneumoniae</i> from other <i>Streptococcus mitis</i> group (SMG) species is still challenging but very important due to their different pathogenic potential. In this study, we aimed to develop a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)-based optochin susceptibility test with an objective read-out. Optimal test performance was established and evaluated by testing consecutively collected respiratory isolates. Optochin in different concentrations as a potential breakpoint concentration was added to a standardized inoculum. Droplets of 6 µL with optochin and, as growth control, without optochin were spotted onto a MALDI target. Targets were incubated in a humidity chamber, followed by medium removal and on-target protein extraction with formic acid before adding matrix with an internal standard. Spectra were acquired, and results were interpreted as <i>S. pneumoniae</i> in the case of optochin susceptibility (no growth), or as non-<i>S. pneumoniae</i> in the case of optochin non-susceptibility (growth). Highest test accuracy was achieved after 20 h incubation time (95.7%). Rapid testing after 12 h incubation time (optochin breakpoint 2 µg/mL; correct classification 100%, validity 62.5%) requires improvement by optimization of assay conditions. The feasibility of the MALDI-TOF MS-based optochin susceptibility test was demonstrated in this proof-of-principle study; however, confirmation and further improvements are warranted.
first_indexed 2024-03-10T06:21:41Z
format Article
id doaj.art-0617987e9c60415e9bdbee5dd398b104
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-03-10T06:21:41Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-0617987e9c60415e9bdbee5dd398b1042023-11-22T19:12:46ZengMDPI AGMicroorganisms2076-26072021-09-01910201010.3390/microorganisms9102010MALDI-TOF Mass Spectrometry-Based Optochin Susceptibility Testing for Differentiation of <i>Streptococcus pneumoniae</i> from other <i>Streptococcus mitis</i> Group StreptococciIlka D. Nix0Evgeny A. Idelevich1Andreas Schlattmann2Katrin Sparbier3Markus Kostrzewa4Karsten Becker5Institute of Medical Microbiology, University Hospital Münster, 48149 Münster, GermanyInstitute of Medical Microbiology, University Hospital Münster, 48149 Münster, GermanyInstitute of Medical Microbiology, University Hospital Münster, 48149 Münster, GermanyBruker Daltonics GmbH & Co. KG, 28359 Bremen, GermanyBruker Daltonics GmbH & Co. KG, 28359 Bremen, GermanyInstitute of Medical Microbiology, University Hospital Münster, 48149 Münster, GermanyDiscrimination of <i>Streptococcus pneumoniae</i> from other <i>Streptococcus mitis</i> group (SMG) species is still challenging but very important due to their different pathogenic potential. In this study, we aimed to develop a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)-based optochin susceptibility test with an objective read-out. Optimal test performance was established and evaluated by testing consecutively collected respiratory isolates. Optochin in different concentrations as a potential breakpoint concentration was added to a standardized inoculum. Droplets of 6 µL with optochin and, as growth control, without optochin were spotted onto a MALDI target. Targets were incubated in a humidity chamber, followed by medium removal and on-target protein extraction with formic acid before adding matrix with an internal standard. Spectra were acquired, and results were interpreted as <i>S. pneumoniae</i> in the case of optochin susceptibility (no growth), or as non-<i>S. pneumoniae</i> in the case of optochin non-susceptibility (growth). Highest test accuracy was achieved after 20 h incubation time (95.7%). Rapid testing after 12 h incubation time (optochin breakpoint 2 µg/mL; correct classification 100%, validity 62.5%) requires improvement by optimization of assay conditions. The feasibility of the MALDI-TOF MS-based optochin susceptibility test was demonstrated in this proof-of-principle study; however, confirmation and further improvements are warranted.https://www.mdpi.com/2076-2607/9/10/2010<i>Streptococcus pneumoniae</i>MALDI-TOF mass spectrometryoptochin susceptibility testingrapid testDOT-MGA
spellingShingle Ilka D. Nix
Evgeny A. Idelevich
Andreas Schlattmann
Katrin Sparbier
Markus Kostrzewa
Karsten Becker
MALDI-TOF Mass Spectrometry-Based Optochin Susceptibility Testing for Differentiation of <i>Streptococcus pneumoniae</i> from other <i>Streptococcus mitis</i> Group Streptococci
Microorganisms
<i>Streptococcus pneumoniae</i>
MALDI-TOF mass spectrometry
optochin susceptibility testing
rapid test
DOT-MGA
title MALDI-TOF Mass Spectrometry-Based Optochin Susceptibility Testing for Differentiation of <i>Streptococcus pneumoniae</i> from other <i>Streptococcus mitis</i> Group Streptococci
title_full MALDI-TOF Mass Spectrometry-Based Optochin Susceptibility Testing for Differentiation of <i>Streptococcus pneumoniae</i> from other <i>Streptococcus mitis</i> Group Streptococci
title_fullStr MALDI-TOF Mass Spectrometry-Based Optochin Susceptibility Testing for Differentiation of <i>Streptococcus pneumoniae</i> from other <i>Streptococcus mitis</i> Group Streptococci
title_full_unstemmed MALDI-TOF Mass Spectrometry-Based Optochin Susceptibility Testing for Differentiation of <i>Streptococcus pneumoniae</i> from other <i>Streptococcus mitis</i> Group Streptococci
title_short MALDI-TOF Mass Spectrometry-Based Optochin Susceptibility Testing for Differentiation of <i>Streptococcus pneumoniae</i> from other <i>Streptococcus mitis</i> Group Streptococci
title_sort maldi tof mass spectrometry based optochin susceptibility testing for differentiation of i streptococcus pneumoniae i from other i streptococcus mitis i group streptococci
topic <i>Streptococcus pneumoniae</i>
MALDI-TOF mass spectrometry
optochin susceptibility testing
rapid test
DOT-MGA
url https://www.mdpi.com/2076-2607/9/10/2010
work_keys_str_mv AT ilkadnix malditofmassspectrometrybasedoptochinsusceptibilitytestingfordifferentiationofistreptococcuspneumoniaeifromotheristreptococcusmitisigroupstreptococci
AT evgenyaidelevich malditofmassspectrometrybasedoptochinsusceptibilitytestingfordifferentiationofistreptococcuspneumoniaeifromotheristreptococcusmitisigroupstreptococci
AT andreasschlattmann malditofmassspectrometrybasedoptochinsusceptibilitytestingfordifferentiationofistreptococcuspneumoniaeifromotheristreptococcusmitisigroupstreptococci
AT katrinsparbier malditofmassspectrometrybasedoptochinsusceptibilitytestingfordifferentiationofistreptococcuspneumoniaeifromotheristreptococcusmitisigroupstreptococci
AT markuskostrzewa malditofmassspectrometrybasedoptochinsusceptibilitytestingfordifferentiationofistreptococcuspneumoniaeifromotheristreptococcusmitisigroupstreptococci
AT karstenbecker malditofmassspectrometrybasedoptochinsusceptibilitytestingfordifferentiationofistreptococcuspneumoniaeifromotheristreptococcusmitisigroupstreptococci